ダウンロード数: 216

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
21_0249.pdf270.15 kBAdobe PDF見る/開く
タイトル: ヒト前立腺肥大症組織とRobaveron 2.前立腺肥大組織のTestosterone代謝におよぼすRobaveronの影響
その他のタイトル: “ROBAVERON” AND HUMAN PROSTATIC TISSUE IN HYPERTROPHY THE EFFECT OF ROBAVERON ON TESTOSTRONE METABOLISM (2) IN HYPERTROPHIC HUMAN PROSTATIC TISSUE
著者: 竹中, 生昌  KAKEN_name
池田, 嘉之  KAKEN_name
小原, ひろみ  KAKEN_name
仲田, 富士徳  KAKEN_name
著者名の別形: Takenaka, Ikumasa
Ikeda, Yoshiyuki
Kohara, Hiromi
Nakada, Fujinori
発行日: Mar-1975
出版者: 京都大学医学部泌尿器科学教室
誌名: 泌尿器科紀要
巻: 21
号: 3
開始ページ: 249
終了ページ: 267
抄録: In order to investigate the effect of Robaveron on prostate, the prostatic tissues surgically removed were incubated with testosterone-4-14C, and then by subcellular fraction of the cultured prostatic tissues, the testosterone metabolites were analyzed. 1) Dihydrotestosterone (DHT), 5a-androstanediol, 5a-androstenedione and , ⊿4-androstene dione were identified as metabolites of testosterone. DHT was most identified. 2) Testosterone metabolism was a little suppressed with Robaveron. In the supernatant of the tissues, the 5a-reduced products were increased. On the contrary, in the nucleic fraction, these were not so much promoted. 3) In view of the production of DHT, it was thought that Robaveron accelerated 5α-reductase activities in cytoplasm, and the conjugation of receptor protein with DHT was retarded. Consequently, it was assumed that Robaveron had a kind of anti-androgenic action.
URI: http://hdl.handle.net/2433/121789
出現コレクション:Vol.21 No.3

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。